These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 20631802)
1. Progress and prospects: foamy virus vectors enter a new age. Erlwein O; McClure MO Gene Ther; 2010 Dec; 17(12):1423-9. PubMed ID: 20631802 [TBL] [Abstract][Full Text] [Related]
2. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs. Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838 [TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors. Bastone P; Romen F; Liu W; Wirtz R; Koch U; Josephson N; Langbein S; Löchelt M Gene Ther; 2007 Apr; 14(7):613-20. PubMed ID: 17203107 [TBL] [Abstract][Full Text] [Related]
4. Low-level expression of functional foamy virus receptor on hematopoietic progenitor cells. von Laer D; Lindemann D; Roscher S; Herwig U; Friel J; Herchenröder O Virology; 2001 Sep; 288(1):139-44. PubMed ID: 11543666 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs. Park J; Nadeau P; Zucali JR; Johnson CM; Mergia A Virology; 2005 Dec; 343(2):275-82. PubMed ID: 16181654 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. Sinn PL; Sauter SL; McCray PB Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340 [TBL] [Abstract][Full Text] [Related]
7. [Prospects for gene therapy in hematology]. Moreau-Gaudry F; Mazurier F; Salesse S; Fontanellas A; Verneuil HD Ann Biol Clin (Paris); 1999; 57(1):43-50. PubMed ID: 9920966 [TBL] [Abstract][Full Text] [Related]
8. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential. Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446 [TBL] [Abstract][Full Text] [Related]
9. Importance of the major splice donor and redefinition of cis-acting sequences of gutless feline foamy virus vectors. Liu W; Backes P; Löchelt M Virology; 2009 Nov; 394(2):208-17. PubMed ID: 19775717 [TBL] [Abstract][Full Text] [Related]
10. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector. Bai Y; Soda Y; Izawa K; Tanabe T; Kang X; Tojo A; Hoshino H; Miyoshi H; Asano S; Tani K Gene Ther; 2003 Aug; 10(17):1446-57. PubMed ID: 12900759 [TBL] [Abstract][Full Text] [Related]
15. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors. Sun Y; Li Z; Li L; Li J; Liu X; Li W Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648 [TBL] [Abstract][Full Text] [Related]